XERIS BIOPHARMA HOLDINGS, INC. (XERS) /
The profitability of XERIS BIOPHARMA HOLDINGS, INC. over the past 6 years
Chart XERIS BIOPHARMA HOLDINGS, INC.: operating income, net income, fiscal 2020–2025 Open the chart →XERIS BIOPHARMA HOLDINGS, INC. reported net income of $554K in fiscal 2025, the latest fiscal year on file. That year it had operating income of $24.9M. It reported a profit in 1 of the 6 years shown, and a loss in fiscal 2020, 2021, 2022, 2023 and 2024.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | $24.9M | $554K |
| 2024ended Dec 31, 2024 | -$33.65M | -$54.84M |
| 2023ended Dec 31, 2023 | -$44.01M | -$62.26M |
| 2022ended Dec 31, 2022 | -$81.94M | -$94.66M |
| 2021ended Dec 31, 2021 | -$115.16M | -$122.72M |
| 2020ended Dec 31, 2020 | -$83.55M | -$91.14M |
Fiscal years as XERIS BIOPHARMA HOLDINGS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on XERIS BIOPHARMA HOLDINGS, INC.
- The revenue of XERIS BIOPHARMA HOLDINGS, INC.
- The cash flow of XERIS BIOPHARMA HOLDINGS, INC.
- The debt of XERIS BIOPHARMA HOLDINGS, INC.
- All of XERIS BIOPHARMA HOLDINGS, INC.'s financials, charted
Companies of a similar size
- VCELVERICEL CORPORATION
- BANCBANC OF CALIFORNIA, INC.
- DRHDIAMONDROCK HOSPITALITY CO
- CIFRCipher Digital Inc.
- ATRCAtriCure, Inc.
Not investment advice. This page shows what XERIS BIOPHARMA HOLDINGS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.